Oseltamivir Treatment for Influenza in Infants

Introduction to Oseltamivir Treatment

The American Academy of Pediatrics recommends oseltamivir treatment for influenza in infants as young as 2 weeks of age, with the 10-month-old infant falling within the approved age range 1, 5, 2

For a 10-month-old infant, the recommended treatment dose is 3.5 mg/kg per dose, given twice daily for 5 days 3, 1, 4, 5, 6, 7, 8
Alternatively, if weight is not available, age-based dosing can be used, with 25 mg (approximately 4.2 mL of the 6 mg/mL suspension) given twice daily for 5 days 9, 3

The oral suspension should be used at a 6 mg/mL concentration 1, 2, 10
If commercial suspension is unavailable, pharmacies can compound it from capsules 3, 1, 2
Treatment should ideally be started within 48 hours of symptom onset for maximum effectiveness, but can still be beneficial when started after 48 hours in children with moderate-to-severe or progressive disease 11, 10, 5, 8
Common adverse events include gastrointestinal effects (nausea, vomiting, diarrhea), headache, and skin reactions 1, 10

Children under 2 years are at increased risk of hospitalization and complications from influenza, and treatment should be offered for any child hospitalized with presumed influenza 5, 8, 3, 11
For premature infants, dosing should be based on postmenstrual age (gestational age + chronologic age) rather than chronologic age alone 1, 4, 6, 7

Do not delay treatment while waiting for laboratory confirmation - clinical judgment based on symptoms during influenza season is sufficient to initiate therapy 11
Do not rely on rapid antigen tests to rule out influenza - these tests have low sensitivity and negative results should not be used to make treatment decisions 11
Do not withhold treatment if >48 hours have passed since symptom onset if the child has moderate-to-severe or progressive disease 11, 5, 8
Ensure accurate weight-based dosing - using age-based dosing when weight is available may result in suboptimal dosing 3, 1